Skip to main content

Find Clinical Trials

Home
Conditions
Myosarcoma

Clinical trial condition

Myosarcoma

Explore clinical trials studying Myosarcoma. Study availability and eligibility vary by location and protocol.

198 public trials 39 recruiting studies

Refine in advanced search Browse all conditions

Myosarcoma trial results

Recruiting

Tumor-Lymph Node Mapping

NCT07054944

Conditions: Germ Cell Tumor, Myosarcoma, Neoplasms, +7 more
Locations: University of Rochester Medical Center Rochester, New York, United States

View Trial Details

Recruiting

Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies

NCT04308330

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ewing Sarcoma, Female Urogenital Diseases, +34 more
Locations: New York Medical College Valhalla, New York, United States

View Trial Details

Recruiting

Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

NCT04715191

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Digestive System Neoplasms, +32 more
Locations: Texas Children's Hospital Houston, Texas, United States

View Trial Details

Recruiting

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

NCT01804634

Conditions: Hepatoblastoma, Myosarcoma, Neoplasms, +19 more
Locations: The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

Albert Einstein College of Medicine, Children's Hospital at Montefiore The Bronx, New York, United States

New York Medical Center/ Maria Fareri Children's Hospital Valhalla, New York, United States

View Trial Details

Recruiting

Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas

NCT06709495

Conditions: Desmoplastic Small Round Cell Tumor, Myosarcoma, Neoplasms, +10 more
Locations: Boston Children's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Brigham and Women's Hospital Boston, Massachusetts, United States

View Trial Details

Recruiting

Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells

NCT07148050

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +40 more
Locations: Seattle Children's Hospital Seattle, Washington, United States

View Trial Details

Recruiting

HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma

NCT04995003

Conditions: Ewing Sarcoma, HER-2 Protein Overexpression, Myosarcoma, +14 more
Locations: Texas Children's Hospital Houston, Texas, United States

View Trial Details

Recruiting

Molecular Analysis Of Solid Tumors

NCT01050296

Conditions: Eye Diseases, Eye Diseases, Hereditary, Eye Neoplasms, +24 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Recruiting

Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells

NCT06198296

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +38 more
Locations: Houston Methodist Hospital Houston, Texas, United States

View Trial Details

Recruiting

Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

NCT02508038

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +40 more
Locations: University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States

View Trial Details